Nobuaki Miyahara Selected Research

Emphysema

1/2024	Pneumocystis jirovecii pneumonia mortality risk associated with preceding long-term steroid use for the underlying disease: A multicenter, retrospective cohort study.
1/2022	Protective effects of neuropeptide Y against elastase-induced pulmonary emphysema.
5/2021	Loss of IL-33 enhances elastase-induced and cigarette smoke extract-induced emphysema in mice.
1/2019	A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation.
11/2016	IL-23 Is Essential for the Development of Elastase-Induced Pulmonary Inflammation and Emphysema.
4/2015	Emphysema requires the receptor for advanced glycation end-products triggering on structural cells.
1/2014	Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
1/2013	IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuaki Miyahara Research Topics

Disease

47	Inflammation (Inflammations) 11/2021 - 10/2003
37	Respiratory Hypersensitivity 01/2019 - 12/2003
16	Eosinophilia 08/2023 - 10/2003
14	Asthma (Bronchial Asthma) 12/2023 - 12/2003
12	Metaplasia 06/2016 - 01/2006
8	Emphysema 01/2024 - 01/2013
8	Pneumonia (Pneumonitis) 10/2021 - 12/2003
7	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 06/2016
7	Idiopathic Pulmonary Fibrosis 09/2023 - 01/2020
6	Fibrosis (Cirrhosis) 09/2023 - 01/2006
5	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2023 - 01/2021
5	Infections 01/2023 - 12/2003
5	Disease Progression 12/2022 - 01/2013
5	Chronic Obstructive Pulmonary Disease (COPD) 09/2021 - 06/2016
4	Pulmonary Emphysema 01/2022 - 01/2013
4	Allergic Rhinitis 12/2008 - 11/2005
4	Hyperplasia 05/2006 - 10/2003
3	Lung Neoplasms (Lung Cancer) 05/2024 - 01/2020
2	Respiratory Insufficiency (Respiratory Failure) 01/2024 - 11/2022
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2024 - 01/2017
2	Neoplasms (Cancer) 02/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 03/2020 - 01/2017
2	Bronchiolitis Obliterans 07/2019 - 12/2011
2	Fever (Fevers) 08/2016 - 06/2011
2	Reinfection 01/2008 - 08/2005
2	Nasal Obstruction 11/2006 - 11/2005
2	Respiratory Syncytial Virus Infections 04/2005 - 12/2003
1	Pulmonary Tuberculosis 05/2024
1	Body Weight (Weight, Body) 01/2024
1	Autoimmune Diseases (Autoimmune Disease) 01/2024
1	Vascular Diseases (Vascular Disease) 09/2023
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 09/2023
1	Bronchopneumonia 12/2022
1	Idiopathic Interstitial Pneumonias 12/2022

Drug/Important Bio-Agent (IBA)

31	AllergensIBA 01/2019 - 10/2003
23	CytokinesIBA 09/2023 - 12/2003
19	Interleukin-13IBA 09/2009 - 12/2003
11	Methacholine Chloride (Methacholine)FDA Link 01/2013 - 12/2003
8	InterleukinsIBA 09/2023 - 10/2003
8	Pancreatic Elastase (Elastase)IBA 01/2022 - 01/2013
8	OvalbuminIBA 12/2017 - 01/2006
7	Leukotriene B4IBA 06/2009 - 04/2005
5	Interleukin-17 (Interleukin 17)IBA 09/2023 - 01/2013
5	ChemokinesIBA 04/2015 - 01/2006
5	Immunoglobulin E (IgE)IBA 06/2009 - 11/2004
5	Interleukin-5 (Interleukin 5)IBA 01/2009 - 02/2004
4	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 07/2008 - 07/2005
3	Interleukin-23 (Interleukin 23)IBA 09/2023 - 11/2016
3	Neuropeptide YIBA 12/2022 - 01/2019
3	Bleomycin (Blenoxane)FDA LinkGeneric 12/2022 - 10/2021
3	Prednisolone (Predate)FDA LinkGeneric 02/2022 - 06/2011
3	Immunoglobulin G (IgG)IBA 09/2021 - 01/2006
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2006
3	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2016 - 04/2008
3	LeukotrienesIBA 01/2014 - 06/2006
3	Interleukin-4 (Interleukin 4)IBA 09/2007 - 02/2004
3	AntigensIBA 06/2006 - 02/2004
2	ErbB Receptors (EGF Receptor)IBA 05/2024 - 03/2020
2	osimertinibIBA 05/2024 - 03/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 01/2013
2	AntibodiesIBA 11/2022 - 11/2004
2	Phosphotransferases (Kinase)IBA 02/2022 - 01/2020
2	SmokeIBA 05/2021 - 01/2019
2	nintedanibIBA 03/2021 - 01/2020
2	pirfenidoneIBA 03/2021 - 05/2020
2	Chemotactic FactorsIBA 01/2019 - 07/2005
2	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2019 - 01/2017
2	Receptor for Advanced Glycation End ProductsIBA 10/2015 - 04/2015
2	AerosolsIBA 01/2013 - 10/2011
2	Interleukin-10 (Interleukin 10)IBA 05/2007 - 02/2007
2	Chemokine CCL5IBA 08/2006 - 01/2006
2	aluminum sulfate (alum)IBA 04/2006 - 01/2006
2	IgE Receptors (Fc epsilon RI)IBA 11/2005 - 05/2004
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024
1	Serum AlbuminIBA 01/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2024
1	Pentamidine (NebuPent)FDA LinkGeneric 01/2024
1	Sulfamethoxazole FDA LinkGeneric 01/2024
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2024
1	SteroidsIBA 01/2024
1	tezepelumabIBA 12/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2023
1	CollagenIBA 09/2023
1	Interleukin-6 (Interleukin 6)IBA 09/2023
1	Platelet-Derived Growth FactorIBA 09/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2023
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2023
1	dupilumabIBA 08/2023
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2023
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2023
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2022
1	neuropeptide Y-Y1 receptorIBA 12/2022
1	Transfer RNA (tRNA)IBA 11/2022

Therapy/Procedure

10	Therapeutics 05/2024 - 11/2006
3	Drug Therapy (Chemotherapy) 01/2020 - 12/2011
2	Extracorporeal Membrane Oxygenation 11/2022 - 12/2011
2	Immunotherapy 08/2016 - 07/2009
2	Aftercare (After-Treatment) 08/2016 - 03/2007
2	Intranasal Administration 01/2008 - 05/2006